Table 1.
Laboratory hormone tests of the two newborns diagnosed with CPHD.
| Hormones | Patients | Normal Ranges | |
|---|---|---|---|
| 1 | 2 | ||
| TSH | 5.66 | <0.004 | 0.5–5 μUI/mL |
| FT4 | 0.784 | 0.776 | 0.8–1.8 ng/dL |
| ACTH | <1 | 3.49 | 7–63 pg/mL |
| Cortisol | 0.523 | 2.87 | 6.24–18 μg/dL |
| D4-Andostenedione | <0.30 | NA | 0.05–0.45 ng/mL |
| DHEA-S | <15 | 29.4 | 6–21 μg/dL |
| LH | <0.1 | <0.1 | 0–1.3 mIU/mL |
| FSH | 0.123 | 0.226 | 0.1–2.4 mIU/mL |
| Testosterone | <20 | 22.5 | 75–400 ng/dL |
| GH | 4.54 | 1.19 | 5–40 ng/mL |
| IGF-1 | <15 | <0.25 | 15–129 ng/mL |
| PRL | 291.5 | 27.06 | 5–20 ng/mL |
| Aldosterone | 1185 | NA | 50–900 pg/mL |
| Renin | 27.6 | NA | <37 ng/mL/h |
Notes: TSH: Thyroid Stimulating Hormone; FT4: Free Thyroxine; ACTH: Adrenocorticotropic Hormone; DHEA-S: Dehydroepiandrosterone-sulfate; LH: Luteinizing Hormone; FSH: Follicle Stimulating Hormone; GH: Growth Hormone; IGF-1: Insulin-like Growth Factor-1; PRL: Prolactin; NA: Not Available.